- Joined
- Jul 23, 2016
- Messages
- 418
- Reaction score
- 224
I recently attended an open-house at a DO school. I asked the 1st yr medical students "what's being done to prepare you for a competitive post-2020 GME application?" Student A said their school is more or less 'highly recommending' 1) the importance of taking USMLE and 2) engaging in research early. Student B said they assumed there would be bias in traditionally DO residencies that would favor the DO applicant, and one could expect the same from traditionally MD residencies.
Student A seems on point. All spots will be competed for come 2020. As such, taking the same tests as MD's is a no-brainer. A shame though, that the DO will have to fork over twice the money for licensing exams (COMPLEX + USMLE) during UGME, compared to their MD counterparts. Research shouldn't hurt either.
Student B shared my same initial thoughts. This path wouldn't be sustainable though right? GME program directors could only get away with favoritism for a few years or so, if any at all with folks looking over their shoulders. With the same test scores (USMLE) and same research experiences and caliber of recommendations, it would only be damaging to respective programs to employ favoritism based on DO/MD, year over year. Not sustainable in my opinion.
MD's simply can't take the COMPLEX without manipulative medicine training. So, everyone takes USMLE. What happens to DO? Will OMM classes be offered during GME for residencies where it would be useful? Does DO disappear in 10 yrs? Or become a niche?
I'm biased a bit towards DO, if at all. I like the extra bit about learning manipulative medicine, particularly how it ties systems together in a fashion that one does not become exposed to during MD. For this reason I hope DO never goes away, unless OMM remains available in UGME or GME.
Thoughts?
Student A seems on point. All spots will be competed for come 2020. As such, taking the same tests as MD's is a no-brainer. A shame though, that the DO will have to fork over twice the money for licensing exams (COMPLEX + USMLE) during UGME, compared to their MD counterparts. Research shouldn't hurt either.
Student B shared my same initial thoughts. This path wouldn't be sustainable though right? GME program directors could only get away with favoritism for a few years or so, if any at all with folks looking over their shoulders. With the same test scores (USMLE) and same research experiences and caliber of recommendations, it would only be damaging to respective programs to employ favoritism based on DO/MD, year over year. Not sustainable in my opinion.
MD's simply can't take the COMPLEX without manipulative medicine training. So, everyone takes USMLE. What happens to DO? Will OMM classes be offered during GME for residencies where it would be useful? Does DO disappear in 10 yrs? Or become a niche?
I'm biased a bit towards DO, if at all. I like the extra bit about learning manipulative medicine, particularly how it ties systems together in a fashion that one does not become exposed to during MD. For this reason I hope DO never goes away, unless OMM remains available in UGME or GME.
Thoughts?
Last edited: